Last Posted: Jul 13, 2022
- Use of illness severity scores to predict mortality in interstitial lung disease patients hospitalised with acute respiratory deterioration
RL WIlliams et al, MEDRXIV, July 12, 2022
- Limited cross-variant immunity from SARS-CoV-2 Omicron without vaccination
RK Suryawanshi et al, Nature, May 18, 2022
- Predicting Usual Interstitial Pneumonia Histopathology from Chest CT with Deep Learning.
Bratt Alex et al. Chest 2022
- State-of-the-art review of lung imaging in cystic fibrosis with recommendations for pulmonologists and radiologists from the "iMAging managEment of cySTic fibROsis" (MAESTRO) consortium.
Ciet Pierluigi et al. European respiratory review : an official journal of the European Respiratory Society 2022 31(163)
- X-Linked Agammaglobulinemia: Infection Frequency and Infection-Related Mortality in the USIDNET Registry.
O'Toole Dana et al. Journal of clinical immunology 2022
- Elexacaftor/Tezacaftor/Ivacaftor in Patients with Cystic Fibrosis Homozygous for the F508del Mutation and Advanced Lung Disease: A 48-Week Observational Study.
Carnovale Vincenzo et al. Journal of clinical medicine 2022 11(4)
- MIXTURE of human expertise and deep learning-developing an explainable model for predicting pathological diagnosis and survival in patients with interstitial lung disease.
Uegami Wataru et al. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2022
- Seasonal variation of lung function in cystic fibrosis: longitudinal modeling to compare a Midwest US cohort to international populations.
Gecili Emrah et al. The Science of the total environment 2022 776
- Compelling Interaction of Cigarette Smoking and Polygenetic Risk Emerges for Lung Function and COPD
DB Hancock et al, JAMA Network Open, December 20, 2021
- Contemporary Clinical and Coronary Anatomic Risk Model for 30-Day Mortality After Percutaneous Coronary Intervention.
Doll Jacob A et al. Circulation. Cardiovascular interventions 2021 CIRCINTERVENTIONS121010863
HLBS-PopOmics is an online, continuously updated, searchable database of published scientific literature, CDC and NIH resources, and other materials that address the translation of genomic and other precision health discoveries into improved health care and prevention related to Heart and Vascular Diseases(H), Lung Diseases(L), Blood Diseases(B), and Sleep Disorders(S)...more
- CDC Information (4)
- NIH Information (15)
- COVID-19 (173)
- CDC Publications (4)
- Human Genome Epidemiologic Studies (606)
- GWAS Studies (22)
- Human Genomics Translation/Implementation Studies (46)
- Genomic Tests Evidence Synthesis (6)
- Genomic Tests Guidelines (5)
- Tier-Classified Guidelines (2)
- Non-Genomics Precision Health (24)
- Pathogen Advanced Molecular Detection (11)
- Reviews/Commentaries (40)
- Ethical/Legal and Social Issues (ELSI) (2)
Mensah GA, Yu W, Barfield WL, Clyne M, Engelgau MM, Khoury MJ. HLBS-PopOmics: an online knowledge base to accelerate dissemination and implementation of research advances in population genomics to reduce the burden of heart, lung, blood, and sleep disorders. Genet Med. 2018 Sep 10. doi: 10.1038/s41436-018-0118-1
Disclaimer: Articles listed in the Public Health Knowledge Base are selected by the CDC Office of Public Health Genomics to provide current awareness of the literature and news. Inclusion in the update does not necessarily represent the views of the Centers for Disease Control and Prevention nor does it imply endorsement of the article's methods or findings. CDC and DHHS assume no responsibility for the factual accuracy of the items presented. The selection, omission, or content of items does not imply any endorsement or other position taken by CDC or DHHS. Opinion, findings and conclusions expressed by the original authors of items included in the update, or persons quoted therein, are strictly their own and are in no way meant to represent the opinion or views of CDC or DHHS. References to publications, news sources, and non-CDC Websites are provided solely for informational purposes and do not imply endorsement by CDC or DHHS.